Viking Therapeutics Inc. (VKTX)

7.69
0.17 2.20
NASDAQ : Health Technology
Prev Close 7.86
Open 7.77
Day Low/High 7.56 / 7.80
52 Wk Low/High 6.15 / 13.78
Volume 681.42K
Avg Volume 1.29M
Exchange NASDAQ
Shares Outstanding 72.21M
Market Cap 537.64M
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Notable Monday Option Activity: VKTX, SSD, TREX

Notable Monday Option Activity: VKTX, SSD, TREX

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Viking Therapeutics Inc , where a total volume of 5,239 contracts has been traded thus far today, a contract volume which is representative of approximately 523,900 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 55.8% of VKTX's average daily trading volume over the past month, of 938,475 shares.

First Week Of VKTX December 20th Options Trading

First Week Of VKTX December 20th Options Trading

Investors in Viking Therapeutics Inc saw new options become available this week, for the December 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VKTX options chain for the new December 20th contracts and identified one put and one call contract of particular interest.

Noteworthy Thursday Option Activity: VKTX, TREE, LMT

Noteworthy Thursday Option Activity: VKTX, TREE, LMT

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Viking Therapeutics Inc , where a total of 9,312 contracts have traded so far, representing approximately 931,200 underlying shares. That amounts to about 60.1% of VKTX's average daily trading volume over the past month of 1.5 million shares.

First Week Of May 2020 Options Trading For Viking Therapeutics (VKTX)

First Week Of May 2020 Options Trading For Viking Therapeutics (VKTX)

Investors in Viking Therapeutics Inc saw new options begin trading this week, for the May 2020 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 233 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Viking Therapeutics To Present At 2019 Cantor Global Healthcare Conference

Viking Therapeutics To Present At 2019 Cantor Global Healthcare Conference

SAN DIEGO, Sept. 25, 2019 /PRNewswire/ -- Viking Therapeutics, Inc.

First Week Of VKTX January 2022 Options Trading

First Week Of VKTX January 2022 Options Trading

Investors in Viking Therapeutics Inc saw new options begin trading this week, for the January 2022 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 857 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Viking Therapeutics To Participate In Upcoming Investor Conferences

Viking Therapeutics To Participate In Upcoming Investor Conferences

SAN DIEGO, Aug. 28, 2019 /PRNewswire/ -- Viking Therapeutics, Inc.

Viking Therapeutics Becomes Oversold (VKTX)

Viking Therapeutics Becomes Oversold (VKTX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Viking Therapeutics Reports Second Quarter 2019 Financial Results And Provides Corporate Update

Viking Therapeutics Reports Second Quarter 2019 Financial Results And Provides Corporate Update

Conference call scheduled for 4:30 p.m. ET today

Viking Therapeutics To Report Financial Results For Second Quarter 2019 On August 1, 2019

Viking Therapeutics To Report Financial Results For Second Quarter 2019 On August 1, 2019

Conference Call Scheduled for Thursday, August 1 at 4:30 p.m. Eastern Time

Viking Therapeutics Appoints Kathy Rouan, Ph.D., To Board Of Directors

Viking Therapeutics Appoints Kathy Rouan, Ph.D., To Board Of Directors

SAN DIEGO, July 2, 2019 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the appointment of...

Viking Therapeutics To Participate In Upcoming Investor Conferences

Viking Therapeutics To Participate In Upcoming Investor Conferences

SAN DIEGO, May 28, 2019 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company...

Interesting VKTX Call Options For April 18th

Interesting VKTX Call Options For April 18th

Investors in Viking Therapeutics Inc saw new options become available this week, for the April 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VKTX options chain for the new April 18th contracts and identified the following call contract of particular interest.

5 Stocks on My Radar During a Quiet Day

5 Stocks on My Radar During a Quiet Day

Sometimes dull action like this can be good for trading.

Lyft's Aggressive IPO Pricing Was a Mistake

Lyft's Aggressive IPO Pricing Was a Mistake

Poor trading action in Lyft will likely create some distrust of upcoming IPOs, and Uber in particular.

The Best Approach to Trading Lyft

The Best Approach to Trading Lyft

Valuation and all the other issues that are being discussed are secondary to the price action.

Is This Market Action Foreshadowing Something Worse?

Is This Market Action Foreshadowing Something Worse?

This trading is starting to create some fairly deep pullbacks.

The Market Close Will Tell Us a Lot About Momentum

The Market Close Will Tell Us a Lot About Momentum

Sharp intraday reversals tend to lead to more selling.

First Week Of March 15th Options Trading For Viking Therapeutics (VKTX)

First Week Of March 15th Options Trading For Viking Therapeutics (VKTX)

Investors in Viking Therapeutics Inc saw new options become available this week, for the March 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VKTX options chain for the new March 15th contracts and identified one put and one call contract of particular interest.

Interesting VKTX Put And Call Options For January 2021

Interesting VKTX Put And Call Options For January 2021

Investors in Viking Therapeutics Inc saw new options begin trading this week, for the January 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 717 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

The Market Is Transitioning Back to Stock Picking

The Market Is Transitioning Back to Stock Picking

There are obvious signs that people are trying to put cash to work.

Quiet Trading Allowing Some Biotech Names to Perk Up

Quiet Trading Allowing Some Biotech Names to Perk Up

After two chaotic days, Wall Street is trading relatively calmly, creating opportunities for individual names to show life.

Oversold Conditions For Viking Therapeutics (VKTX)

Oversold Conditions For Viking Therapeutics (VKTX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

VKTX: Insiders Vs. Shorts

VKTX: Insiders Vs. Shorts

The most recent short interest data was recently released for the 10/31/2018 settlement date, and Viking Therapeutics Inc is one of the most shorted stocks of the Russell 3000, based on 7.60 "days to cover" versus the median component at 4.44. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Viking Therapeutics Shows How Quickly This Market Can Turn

Viking Therapeutics Shows How Quickly This Market Can Turn

If you are trying to pick stocks for the longer term it can be quite challenging right now.

This Is Not Just a Market of Oversold Bounces Now

This Is Not Just a Market of Oversold Bounces Now

What is most interesting about the action today is a spike in the speculative action.

My Stock of the Week: ENDRA Life Sciences

My Stock of the Week: ENDRA Life Sciences

I'm simply focusing on individual stocks at this point and am not too concerned about the macro picture.

It Was a Very Rough Week

It Was a Very Rough Week

Just when you thought the worst was over another wave of selling would hit.